1. Home
  2. RCKT vs PRG Comparison

RCKT vs PRG Comparison

Compare RCKT & PRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PRG
  • Stock Information
  • Founded
  • RCKT 1999
  • PRG 2020
  • Country
  • RCKT United States
  • PRG United States
  • Employees
  • RCKT N/A
  • PRG N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PRG Diversified Commercial Services
  • Sector
  • RCKT Health Care
  • PRG Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • PRG Nasdaq
  • Market Cap
  • RCKT 1.3B
  • PRG 1.8B
  • IPO Year
  • RCKT N/A
  • PRG N/A
  • Fundamental
  • Price
  • RCKT $12.72
  • PRG $42.29
  • Analyst Decision
  • RCKT Strong Buy
  • PRG Buy
  • Analyst Count
  • RCKT 11
  • PRG 6
  • Target Price
  • RCKT $50.27
  • PRG $53.00
  • AVG Volume (30 Days)
  • RCKT 1.6M
  • PRG 366.4K
  • Earning Date
  • RCKT 02-24-2025
  • PRG 02-19-2025
  • Dividend Yield
  • RCKT N/A
  • PRG 1.14%
  • EPS Growth
  • RCKT N/A
  • PRG 8.67
  • EPS
  • RCKT N/A
  • PRG 3.58
  • Revenue
  • RCKT N/A
  • PRG $2,417,577,000.00
  • Revenue This Year
  • RCKT N/A
  • PRG $2.85
  • Revenue Next Year
  • RCKT $233,736.97
  • PRG $6.70
  • P/E Ratio
  • RCKT N/A
  • PRG $11.80
  • Revenue Growth
  • RCKT N/A
  • PRG N/A
  • 52 Week Low
  • RCKT $11.15
  • PRG $27.84
  • 52 Week High
  • RCKT $31.47
  • PRG $50.28
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 47.75
  • PRG 36.80
  • Support Level
  • RCKT $11.56
  • PRG $41.00
  • Resistance Level
  • RCKT $12.32
  • PRG $43.22
  • Average True Range (ATR)
  • RCKT 0.71
  • PRG 1.48
  • MACD
  • RCKT 0.20
  • PRG -0.14
  • Stochastic Oscillator
  • RCKT 66.81
  • PRG 16.60

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About PRG PROG Holdings Inc.

PROG Holdings Inc is a financial technology holding company that provides transparent and competitive payment options to consumers. The Company has two reportable segments: (i) Progressive Leasing, an in-store, app-based, and e-commerce point-of-sale lease-to-own solutions provider; and (ii) Vive Financial (Vive), an omnichannel provider of second-look revolving credit products. The majority of the revenue of the company is earned through the progressive leasing segment.

Share on Social Networks: